Driven by the vital need to develop better therapies for Advanced Heart Failure

Welcome to LoneStar Heart, Inc.

LoneStar Heart, Inc. is a disease-focused company developing breakthrough therapies to preserve and restore adequate heart function in patients with Advanced Heart Failure (HF), a condition that affects millions of ageing patients worldwide. Applying the latest insights from bioengineering, mathematical modeling, molecular biology, and clinical research, the company is advancing a number of product candidates that combine practical and cost-effective solutions with superior clinical outcomes.


LoneStar Heart's products are for investigational use only, and are not currently cleared for sale. 

Algisyl is obtained the CE Mark and approved for sale in the European Union. Algisyl is not approved for sale in the USA.